Ben Franklin Technology Partners of Southeastern Pennsylvania

Houwzer, LLC is a real estate brokerage based in Philadelphia, Pennsylvania, with additional offices in Washington, D.C., Baltimore, Maryland, and Haddonfield, New Jersey. Established in 2014, Houwzer provides comprehensive services for buying and selling homes, emphasizing a customer-centric approach. The company employs salaried agents and loan officers, enabling them to prioritize client service over sales commissions. Houwzer utilizes proprietary technology to streamline the entire real estate transaction process, offering an integrated platform that includes communication tools, featured listings, and transaction management services. With a focus on transparency and efficiency, Houwzer has achieved a high Net Promoter Score and consistently receives positive client reviews. Since its inception, the company has helped clients in the Mid-Atlantic region save significantly when selling their homes and has facilitated thousands of successful transactions.

Corridor Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutic small molecule inhibitors of arginase. Its arginase is an enzyme that competes with endothelial nitric oxide synthase for the use of the common substrate l-arginine. The company's arginase also leads to the production of ornithine which increases polyamine, stimulating cell division, and contributing to hyperplasia and fibrosis. Corridor Pharmaceuticals, Inc. was formerly known as Arginetix, Inc. and changed its name to Corridor Pharmaceuticals, Inc. on June 17, 2010. The company was founded in 2007 and is based in Lutherville, Maryland.